Drug Trial Radar · NCT03110029
Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish
Last checked: Nov 20, 2026Latest source record: Jun 27, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13
Actual
Start
Sep 2015
Primary completion
May 2017
Study completion Jul 2018
Sponsor
- Lead sponsor
- University of Alabama at BirminghamAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Apr 12, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Female only, from 19 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will test how well efinaconazole solution (Jublia) works to treat toenail fungal infections in patients who wear polish compared to those who do not.
Conditions
- Onychomycosis of Toenail
Interventions
Efinaconazole 10% Topical Application Solution [JUBLIA]Drug
Topical efinaconazole 10% solution (Jublia)
Application of Nail PolishOther
Application of Nail Polish
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Nail Polish Disruption Using the Likert ScaleTime frame: 52 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Kirklin Clinic
Birmingham, Alabama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.